⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
globenewswire.com
ATRA
Silicon Valley 101 and Power HF Host AI Infrastructure Forum, Spotlighting Power as the Next Battleground
globenewswire.com
NVDA
GE
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
accessnewswire.com
IBRX
Pomerantz LLP Reminds Shareholders with Losses on their Investment in Gartner, Inc. – IT
accessnewswire.com
IT
ROSEN, A LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
accessnewswire.com
ADMA
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Trip.com Group Limited – TCOM
accessnewswire.com
TCOM
Pomerantz LLP Issues Important Reminder to Vital Farms, Inc. Investors – VITL
accessnewswire.com
VITL
BSX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
accessnewswire.com
BSX
ROSEN, Global Investor Counsel, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
accessnewswire.com
ATRA
AQST DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
accessnewswire.com
AQST